Solomon Moshkevich - 27 Feb 2026 Form 4 Insider Report for Natera, Inc. (NTRA)

Reporting relationship: PRESIDENT, CLINICALDIAGNOSTICS
Issuer ticker: NTRA
Reported as of: 27 Feb 2026
Net transaction value: -$550,396
SEC form: 4
Accepted by SEC: 03 Mar 2026, 21:05:04 UTC
Prior SEC filing: 04 Feb 2026
Next SEC filing: 11 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Tami Chen, Attorney-in-Fact

Key filing fact

Solomon Moshkevich filed Form 4 for Natera, Inc. (NTRA) on 03 Mar 2026.

Key facts

This page summarizes Solomon Moshkevich's Form 4 filing for Natera, Inc. (NTRA).
6 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 03 Mar 2026, 21:05.

Change

Previous filing in this sequence was filed on 04 Feb 2026.
Current net transaction value: -$550,396.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002010019 Primary reporting owner

Moshkevich Solomon

Relationship: PRESIDENT, CLINICALDIAGNOSTICS
Address: C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN
Signature: /s/ Tami Chen, Attorney-in-Fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Award

Transaction value
Shares: +10,051
Change %: +7.3%
Price
Shares after: 147,898
Date: 27 Feb 2026
Ownership: Direct
Footnotes: F1, F2

NTRA transaction

Common Stock

Options Exercise

Transaction value: $49,149
Shares: +5,125
Change %: +3.5%
Price: $9.59
Shares after: 153,023
Date: 02 Mar 2026
Ownership: Direct

NTRA transaction

Common Stock

Sale

Transaction value: $185,114
Shares: -931
Change %: -0.61%
Price: $198.83
Shares after: 152,092
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3, F4

NTRA transaction

Common Stock

Sale

Transaction value: $318,971
Shares: -1,594
Change %: -1%
Price: $200.11
Shares after: 150,498
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3, F5

NTRA transaction

Common Stock

Sale

Transaction value: $95,460
Shares: -475
Change %: -0.32%
Price: $200.97
Shares after: 150,023
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F3, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTRA transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value: $0
Shares: -5,125
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,125
Exercise price: $9.59
Footnotes: F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 7 footnotes

Footnote F1

Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person. The RSUs vest over four years. 25% of the RSUs vest on March 1, 2027 and the remaining RSUs vest in 12 equal quarterly installments thereafter.

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F3

The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 26, 2024.

Footnote F4

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.42 to $199.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.6750 to $200.5100 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.72 to $201.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The option shares are fully exercisable.